LONDON--(BUSINESS WIRE)--Marking a new milestone for artificial intelligence (AI) adoption in the Australian and New Zealand breast screening community, the Mia® solution, created by United ...

A new AI tool from Kheiron Medical Technologies and Imperial College London can detect up to 13% more breast cancers than humans in breast screenings. In 2020, 2.3 million women were diagnosed with ...

CHICAGO, Nov. 27, 2018 /PRNewswire/ -- RSNA - Kheiron Medical Technologies has been granted government funding to test its deep learning breast cancer screening software within the NHS. The funding ...

VIENNA, March 1, 2019 /PRNewswire/ -- European Congress of Radiology - AI diagnostics company Kheiron Medical is today announcing the launch of Mia™, a breast cancer screening solution that supports ...

LONDON, Nov. 29, 2021 /PRNewswire/ -- Kheiron Medical Technologies today announced its new collaboration with researchers at Stanford University to design functional proof-of-concept deep learning ...

Kheiron Medical Technologies, is an applied science company, announced its new collaboration with researchers at Stanford University to design functional proof-of-concept deep learning models to solve ...

Doha: Mia, a deep learning artificial intelligence (AI) solution that works with radiologists to improve breast cancer detection, avoid unnecessary biopsies and ultimately improve the patient ...